|
|
 Controlled Drugs and Substances Act
 SCHEDULE II
(Sections 2, 3, 4 to 7, 10, 29, 55 and 60)
1. Cannabis, its preparations, derivatives and similar synthetic preparations, including
(1) Cannabis resin
(2) Cannabis (marihuana)
(3) Cannabidiol (2–[3–methyl–6–(1–methylethenyl)–2–cyclohexen–1–yl]–5–pentyl–1,3–benzenediol)
(4) Cannabinol (3–n–amyl–6,6,9–trimethyl–6–dibenzopyran–1–ol)
(5) Nabilone ((±)–trans–3–(1,1–dimethylheptyl)–6,6a, 7,8,10,10a–hexahydro–1–hydroxy–6,6–dimethyl–9H–dibenzo[b,d]pyran–9–one)
(6) Pyrahexyl (3–n–hexyl–6,6,9–trimethyl–7,8,9, 10–tetrahydro–6–dibenzopyran–1–ol)
(7) Tetrahydrocannabinol (tetrahydro–6,6,9–trimethyl–3–pentyl–6H–dibenzo[b,d]pyran–1–ol)
(7.1) 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
but not including
(8) Non–viable Cannabis seed, with the exception of its derivatives
(9) Mature Cannabis stalks that do not include leaves, flowers, seeds or branches; and fiber derived from such stalks
1996, c. 19, Sch. II; SOR/98-157; SOR/2003-32, s. 1.
 SCHEDULE III
( Sections 2 to 7, 29, 55 and 60)
1. Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
(1) amphetamine (a–methylbenzeneethanamine)
(2) [Repealed, SOR/2005–235, s. 2]
(3) N–ethylamphetamine (N–ethyl–a–methylbenzeneethanamine)
(4) 4–methyl–2,5–dimethoxyamphetamine (STP) (2,5–dimethoxy–4,a–dimethylbenzeneethanamine)
(5) 3,4–methylenedioxyamphetamine (MDA) (a–methyl–1,3–benzodioxole–5–ethanamine)
(6) 2,5–dimethoxyamphetamine (2,5–dimethoxy–a–methylbenzeneethanamine)
(7) 4–methoxyamphetamine (4–methoxy–a–methylbenzeneethanamine)
(8) 2,4,5–trimethoxyamphetamine (2,4,5–trimethoxy–a–methylbenzeneethanamine)
(9) N–methyl–3,4–methylenedioxyamphetamine (N,a–dimethyl–1,3–benzodioxole–5–ethanamine)
(10) 4–ethoxy–2,5–dimethoxyamphetamine (4–ethoxy–2,5–dimethoxy–a–methylbenzeneethanamine)
(11) 5–methoxy–3,4–methylenedioxyamphetamine (7–methoxy–a–methyl–1,3–benzodioxole–5–ethanamine)
(12) N,N–dimethyl–3,4–methylenedioxyamphetamine (N,N, a–trimethyl–1,3–benzodioxole–5–ethanamine)
(13) N–ethyl–3,4–methylenedioxyamphetamine (N–ethyl–a–methyl–1,3–benzodioxole–5–ethanamine)
(14) 4–ethyl–2,5–dimethoxyamphetamine (DOET) (4–ethyl–2,5–dimethoxy–a–methylbenzeneethanamine)
(15) 4–bromo–2,5–dimethoxyamphetamine (4–bromo–2,5–dimethoxy–a–methylbenzeneethanamine)
(16) 4–chloro–2,5–dimethoxyamphetamine (4–chloro–2,5–dimethoxy–a–methylbenzeneethanamine)
(17) 4–ethoxyamphetamine (4–ethoxy–a–methylbenzeneethanamine)
(18) Benzphetamine (N–benzyl–N,a–dimethylbenzeneethanamine)
(19) N–Propyl–3,4–methylenedioxyamphetamine (a–methyl–N–propyl–1,3–benzodioxole–5–ethanamine)
(20) N–(2–Hydroxyethyl)–a–methylbenzeneethanamine
(21) N-hydroxy-3,4-methylenedioxyamphetamine (N-[a-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
(22) 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-a-methylbenzeneethanamine)
but not including
(23) Methamphetamine (N,a-dimethylbenzeneethanamine)
2. Methylphenidate (a–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof
3. Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof
4. Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof
5. Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof
6. N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof
7. N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof
8. N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof
9. Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof
10. Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof
11. Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof
12. Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof
13. N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof
14. 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof
15. 1–Phenyl–N–propylcyclohexanamine and any salt thereof
16. Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
17. Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
18. 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof
19. Cathinone ((–)–a–aminopropiophenone) and any salt thereof
20. Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof
21. 2–Methylamino–1–phenyl–1–propanone and any salt thereof
22. 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof
23. 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof
24. 4–bromo–2,5–dimethoxybenzeneethanamine and any salt, isomer or salt of isomer thereof
25. Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
26. 4-hydroxybutanoic acid (GHB) and any salt thereof
27. Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof
28. Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
29. Lefetamine ((-)-N,N-dimethyl-a-phenylbenzeneethanamine) and any salt thereof
30. Mesocarb (3-(a-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
31. Zipeprol (4-(2-methoxy-2-phenylethyl)-a-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
32. Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
1996, c. 19, Sch. III; SOR/97-230, ss. 7 to 10; SOR/98-173, s. 1; SOR/2000-220, s. 1; SOR/2003-32, ss. 2, 3, 4(F), 5; SOR/2003-412; SOR/2005-235, s. 2.
Subsections 1-3
Subsections 4-23
Subsections 24-32
Subsections 33-60
Subsections 61-95
Schedule I
Schedule II-III (This page)
Schedule IV-V
Schedule VI-VIII
|
|
|
